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Experimental design 
Experimental design in summarised in Supplementary Figure 1, below. 
Supplementary Figure 1: An illustration of the experimental design including the different control 
samples and their respective incubation. On the right is the experimental setup with the sample in 
an Eppendorf tube with a hole in the lid for gaseous exchange inside a universal tube with the lid 
loosely placed to allow gas exchange with the anaerobic environment. Damp tissue paper was 
placed at the bottom of the tube to minimise evaporation of the sample.  
 
 
 
Supplementary methodology  
Sample analyses  
Bacterial load 
Final bacterial load was assessed post-incubation. Samples were vortexed to homogenise the 
bacterial content and sample was serially diluted ten-fold to 1:105. Samples diluted to 1:103 and 
1:105 were plated (20 µl) onto fastidious anaerobe agar with 5% defibrinated horse blood. Plates 
were incubated under anaerobic conditions for 48 hours, colonies counted and CFU/ml calculated.     
Protein quantification 
Bacterial cells were removed by centrifugation at 15,000 g for ten minutes at 4 °C. Samples were 
analysed by SDS-PAGE as previously described (Gardner and Carpenter 2019). Briefly, 12 µl buffered 
sample was added per lane, electrophoresed and stained with Coomassie Brilliant Blue R250 (Sigma, 
Gillingham, UK). Samples of the unincubated parotid saliva and incubated, PBS-inoculated parotid 
saliva were run on every gel. Destained gels were imaged with a ChemiDoc MP system (Biorad, 
Watford, UK) and analysed in ImageLab 5.2.1 (Bio-Rad Laboratories, Hercules, CA, USA). Total lane 
density of sample lanes and PBS-inoculated lanes relative to the unincubated parotid saliva lanes 
were measured. Bacterial pellets were retained for analysis confirming the protein changes observed 
in saliva (Supplementary Figure 2). 
1H-NMR spectroscopy 
Centrifuged samples were prepared and analysed using internal standard as described (Gardner et 
al. 2018). All reagents and consumables were purchased from sigma. NMR buffer was prepared with 
0.5 mM trimethylsilyl-[2,2,3,3,-2H4]-propionate (TSP) standard, 0.2 M Na2HPO4 and 44 mM NaH2PO4 
in 50% deuterium oxide (D2O) by volume. Sample (440 µl), centrifuged as for the protein analysis, 
was mixed with NMR buffer (110 µl) in 5 mm external diameter NMR tubes to give a final 
concentration of 0.1 mM TSP and 10% by volume D2O. Using a 600 MHz spectrometer (Bruker, 
Karlsruhe, Germany), operating at a proton frequency of 600.2 MHz, spectra were acquired at 25 °C 
using a Carr-Purcell-Meiboom-Gill (CPMG) spin-echo pulse sequence with presaturation to supress 
macromolecule resonances from the spectra. The total echo time was 64 ms with relaxation delay of 
4 s and acquisition time of 2.32 s. Following four dummy scans, 128 transients were collected with 
64,000 data points and spectral width of 20 ppm (−5 to 15 ppm). Spectra were automatically phased 
and baseline corrected with further manual adjustment where required. The control samples 
described for the protein analysis were also analysed by 1H-NMR spectroscopy. An additional non-
incubated sample of parotid saliva with 4% pooled WMS added was prepared to control for baseline 
metabolite content of the inoculum.  
Spectra were analysed by targeted manual quantification of known metabolites. Peak assignments 
were made using HMDB (hmdb.ca), Chenomx 8.3 (Edmonton, Canada) and literature values. Spectra 
were integrated into 0.01 ppm buckets from δ 0.7 to 8.5 ppm, excluding δ 4.5 to 5.5 ppm buckets, 
using MestreC (Santiago de Compostela, Spain), normalised to the standard peak, centred and 
Pareto scaled and then analysed by principal component analysis and k-means cluster analysis in 
Knime v.3.4.2 (Konstanz, Germany).  
 
 
 
Analysis of bacterial pellets 
Microbial pellets were analysed for protein content to ensure protein absent from saliva had not 
simply been aggregated by bacteria, something that certain oral bacterial species are capable of.  
Bacterial pellets were resuspended in 500 µl sterile PBS. A protease inhibitor cocktail (Class I, Sigma) 
was added as instructed (1% by volume) to prevent any further potential protein degradation during 
preparation/analysis. Resuspended bacteria were ultrasonically lysed (ten two second pulses, with 
five seconds in between to prevent heat build-up) and samples of the suspension with and without 
pellet fragments were prepared for SDS-PAGE as described. An example gel is shown below in 
Supplementary Figure 2, confirming that there is negligible residual protein in the bacterial pellets 
and that no protein was lost during pellet preparation. Protein losses from inoculated PS were 
therefore due to protein catabolism rather than aggregation by bacteria. 
    
Supplementary Figure 2: Coomassie stained polyacrylamide gel showing parotid saliva (lane 1) and 
the lack of residual proteins within bacterial pellets (lanes 2 – 7) or PBS when preparing pellets (lanes 
8 – 13). Very faint bands can be seen around the amylase bands in the PBS samples, however this 
does not account for the degree of protein loss observed in incubated inoculated samples. This gel 
appearance was typical for all samples. 
 
 
 
Sensory Scale 
An example of the generalised labelled visual analogue scale (glVAS) is shown in Supplementary 
Figure 3. Note the sucrose concentration is left blank at the point of rating the scale to reduce rating 
bias. 
 
Supplementary Figure 3: Example glVAS used for assessing sucrose intensity.  
 
Example 1H-NMR spectra of PBS and bacteria inoculated parotid saliva 
A comparison of the metabolic content of parotid saliva pre- and post-inoculation and incubation 
with oral bacteria is presented in Supplementary Figure 4. The consumption of host derived urea, 
citrate and lactate is visible as is the generation of SCFAs, amino acids and phenolic compounds.  
Supplementary Figure 4: Partial 1D 600 MHz CPMG 1H-NMR spectra comparing PBS-inoculated 
parotid saliva (top spectrum) and tongue biofilm-inoculated parotid saliva (bottom spectra). The 
water peak region 4.2 – 5.2 ppm has been excluded. Aromatic spectral regions (5.2 – 8.5 ppm) are 
vertically scaled 16 times greater than aliphatic regions (0.78 – 4.2 ppm). Acetate and propionate 
peaks have been cropped (black bars). Spectra are to the same vertical scale.  
 
 
Association between salivary protein consumption and metabolite generation by oral bacteria 
 
Supplementary Figure 5: A summary of the significant (p < 0.05) correlations between protein 
consumption (control lane density minus sample lane density) and change in metabolite 
concentration. Negative correlation indicates consumption of metabolites whereas positive 
correlation indicates production of metabolites.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Figure 6: Assessment of inter-individual variation of metabolite profiles of inoculated 
parotid saliva and participants baseline WMS. Following PCA analysis of the samples, variation was 
assessed by measuring Euclidean distance (weighted for PCA score of the first three axes) between 
participants for each sample type. A total of fifteen measurements per sample type were made (i.e. 
all possible pairings from six participants). Mean Euclidean distance was normalised to the anterior 
tongue samples, which yielded the highest inter-individual variation. ANOVA revealed no significant 
differences between the inter-individual variation of metabolite profiles for the different sample 
types.  
 
 
Supplementary Figure 7: A summary of oral microbial metabolic pathways. a. depicts the interactions following oral exposure to sucrose whereas b. depicts 
interactions in a “fasted” state where the main substrates are amino acids derived from salivary proteins. PEP = phosphoenolpyruvate, OAA = oxaloacetate, 
CoA = coenzyme A. Information is summarised from Takahashi (2015), Owen et al., (2002), Wunderlichova et al., (2014), Smith & Macfarlane (1997), Ajdic 
et al., (2002) and Fernandez-Valero & Vendrell (2019). 
 
Supplementary Table 1: Summary of the concentrations of metabolites consumed and generated 
following 24 h anaerobic incubation of parotid saliva inoculated with oral bacteria relative to 
inoculation with sterile PBS. Significant results (p < 0.05) are presented in bold. NA = statistical test 
could not be conducted due to total consumption of metabolite from all samples yielding a S.D. of 
zero; n.s. = not significant. Sample means were compared to PBS metabolite concentrations by a 
one-sample t-test (n = 6).  
Metabolite Post-
incubation 
metabolite 
conc. 
(mM) for 
PBS 
inoculated 
PS (n=1) 
Mean (S.D.) post-incubation 
metabolite conc. (mM) for PS 
inoculated with: 
p-value between bacterial 
and PBS inoculum (one-
sample t-test). 
Tongue 
biofilm 
(ant.) 
(n=6) 
Tongue 
biofilm 
(post.) 
(n=6) 
WMS 
(n=6) 
Posterior 
tongue 
v. PBS 
control 
Anterior 
tongue 
v. PBS 
control 
WMS 
v. PBS 
control 
Metabolites consumed 
Urea 0.07 0.00 (0.00) 0.00 (0.00) 0.02 (0.01) NA NA 0.01 
Lactate 0.18 0.03 (0.02) 0.02 (0.01) 0.15 (0.01) < 10-5 < 10-5 n.s. 
Citrate 0.08 0.01 (0.01) 0.00 (0.00) 0.03 (0.02) < 10-5 NA 0.004 
Pyruvate 0.05 0.02 (0.01) 0.01 (0.01) 0.03 (0.02) < 10-5 < 10-5 n.s. 
Glucose  0.12 0.00 (0.00) 0.00 (0.00) 0.00 (0.00) NA NA NA 
Metabolites generated 
Formate 0.004 0.77 (0.18) 0.92 (0.17) 0.72 (0.26) < 10-4 < 10-5 0.001 
Phenylalanine 0.02 0.08 (0.04) 0.11 (0.09) 0.05 (0.02) 0.015 n.s. 0.02 
Phenol 0.00 0.16 (0.05) 0.13 (0.04) 0.05 (0.04) < 10-4 < 10-4 0.03 
Proline 0.00 0.37 (0.11) 0.45 (0.17) 0.32 (0.17) < 10-4 0.001 0.006 
Valine 0.00 0.19 (0.10) 0.20 (0.12) 0.10 (0.06) 0.005 0.01 0.01 
Phenylacetate 0.00 0.09 (0.05) 0.05 (0.04) 0.01 (0.01) 0.01 0.02 0.03 
Glycine 0.02 0.50 (0.21) 0.58 (0.32) 0.41 (0.23) 0.003 0.008 0.008 
5-
aminopentanoate 
0.00 1.06 (0.41) 1.04 (0.43) 0.50 (0.31) 0.001 0.002 0.01 
3-
phenylpropionate 
0.00 0.13 (0.11) 0.10 (0.10) 0.01 (0.02) 0.03 n.s. n.s. 
Putrescine 0.00 0.32 (0.09) 0.32 (0.06) 0.17 (0.08) < 10-4 < 10-5 0.004 
Succinate 0.04 0.05 (0.05) 0.09 (0.07) 0.09 (0.03) n.s. n.s. < 10-4 
Acetate 0.01 4.70 (1.02) 4.19 (1.02) 1.85 (0.84) < 10-5 < 10-4 0.003 
Butyrate 0.00 0.62 (0.25) 0.47 (0.25) 0.06 (0.01) 0.002 0.007 n.s. 
Propionate 0.00 2.33 (0.83) 1.97 (0.79) 0.37 (0.40) 0.001 0.002 n.s. 
Leucine 0.02 0.10 (0.06) 0.12 (0.09) 0.07 (0.04) 0.02 0.05 0.02 
 
 
 
 
 
 
 
 
Table 2: A summary of the salivary concentrations and output changes of salivary metabolites post-
sucrose exposure, relative to water control. * - glucose is measured as the sum of α- and β-glucose 
quantified in the sample. Data were analysed by paired t-test (n = 18). Significant p-values (p < 0.05) 
are included in bold. 
Metabolite Salivary metabolite concentration (mM): Salivary metabolite output (µmol/min): 
Post-control 
(water)  
Post-sucrose 
(0.25 M) 
p-value 
(paired 
t-test) 
Post-control 
(water)  
Post-sucrose 
(0.25 M) 
p-value 
(paired t-
test) Mean S.D. Mean S.D. Mean S.D. Mean S.D. 
Formate 0.068  0.118 0.056 0.063 0.54 0.128  0.193 0.122  0.138 0.89 
Sucrose  0.007 0.013 18.39 9.90 4.43x10-7 0.012 0.025 38.35 25.87 8.16x10-6 
Citrate 0.046 0.029 0.042 0.028 0.62 0.089 0.061 0.099 0.075 0.42 
Succinate 0.18 0.13 0.72 0.42 1.84x10-5 0.35 0.25 1.51 0.85 8.54x10-6 
Pyruvate 0.18 0.07 0.40 0.19 4.31x10-5 0.33 0.15 0.84 0.38 6.63x10-6 
Acetate 4.94 2.34 4.16 1.79 0.023 9.53 5.09 8.87 4.09 0.38 
Alanine 0.13 0.06 0.15 0.07 0.021 0.25 0.13 0.33 0.17 0.003 
Acetoin 0.06 0.03 0.11 0.08 0.004 0.12 0.06 0.23 0.16 0.001 
Lactate 0.53 0.53 4.42 2.84 1.31x10-5 0.92 0.81 9.12 5.59 1.14x10-5 
Propionate 0.98 0.64 1.11 0.62 0.19 1.85 1.20 2.33 1.36 0.047 
Butyrate 0.31 0.13 0.27 0.12 0.005 0.60 0.30 0.57 0.26 0.56 
Glucose* 0.15 0.01 3.91 2.06 0.006 0.30 0.03 7.52 4.02 0.007 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplementary Table 3: Summary of the salivary metabolite changes following exposure to a sucrose 
challenge, subdivided by participant sensitivity to the sucrose stimulus. Data are presented as 
concentration and output.  
Metabolite concentration (mM): 
Metabolite Relatively insensitive perceivers (n=9) Sensitive perceivers (n=9) 
Post-control 
(water)  
Post-sucrose 
(0.25 M) 
p-value 
(paired 
t-test) 
Post-control 
(water)  
Post-sucrose 
(0.25 M) 
p-value 
(paired 
t-test) Mean S.D. Mean S.D. Mean S.D. Mean S.D. 
Formate 0.059 0.043 0.045 0.051 0.33 0.078 0.166 0.066 0.074 0.78 
Sucrose  0.008 0.015 20.15 12.12 0.001 0.006 0.012 16.64 7.37 0.0001 
Citrate 0.045 0.032 0.029 0.021 0.025 0.046 0.028 0.055 0.029 0.44 
Succinate 0.19 0.09 0.75 0.47 0.009 0.18 0.17 0.70 0.39 0.0007 
Pyruvate 0.19 0.04 0.40 0.20 0.019 0.17 0.10 0.40 0.20 0.0006 
Acetate 4.77 0.76 4.00 1.35 0.15 5.11 3.31 4.32 2.22 0.10 
Alanine 0.13 0.03 0.14 0.06 0.39 0.13 0.08 0.16 0.09 0.001 
Acetoin 0.07 0.02 0.12 0.07 0.042 0.06 0.04 0.10 0.10 0.058 
Lactate 0.55 0.39 4.63 2.59 0.003 0.50 0.66 4.21 3.21 0.004 
Propionate 0.96 0.31 1.08 0.48 0.48 0.99 0.89 1.13 0.77 0.22 
Butyrate 0.30 0.05 0.23 0.05 0.015 0.32 0.18 0.30 0.15 0.17 
Glucose* 0.15 0.05 4.30 5.38 0.05 0.16 0.05 3.52 5.18 0.09 
 
Salivary metabolite output (µmol/ml): 
Metabolite 
 
Relatively insensitive perceivers (n=9) Sensitive perceivers (n=9) 
Post-control 
(water)  
Post-sucrose 
(0.25 M) 
p-value 
(paired 
t-test) 
Post-control 
(water)  
Post-sucrose 
(0.25 M) 
p-value 
(paired 
t-test) Mean S.D. Mean S.D. Mean S.D. Mean S.D. 
Formate 0.116 0.102 0.103 0.126 0.63 0.141 0.262 0.142 0.154 0.99 
Sucrose  0.015 0.031 31.00 14.56 0.0002 0.010 0.018 45.69 32.99 0.003 
Citrate 0.075 0.049 0.057 0.047 0.11 0.104 0.070 0.142 0.076 0.07 
Succinate 0.33 0.20 1.37 1.06 0.014 0.38 0.29 1.66 0.59 0.0001 
Pyruvate 0.31 0.13 0.72 0.44 0.015 0.36 0.17 0.96 0.27 0.0001 
Acetate 7.96 3.76 7.35 4.24 0.44 11.11 5.94 10.38 3.51 0.60 
Alanine 0.22 0.12 0.28 0.21 0.15 0.27 0.14 0.38 0.12 0.007 
Acetoin 0.11 0.06 0.24 0.20 0.06 0.12 0.07 0.23 0.11 0.0009 
Lactate 0.86 0.61 8.82 7.25 0.013 0.97 1.01 9.42 3.67 0.0001 
Propionate 1.61 0.79 2.09 1.51 0.18 2.09 1.52 2.58 1.23 0.18 
Butyrate 0.48 0.17 0.43 0.20 0.20 0.71 0.36 0.72 0.24 0.90 
Glucose* 0.05 0.02 3.32 5.22 0.10 0.07 0.04 2.47 2.57 0.023 
 
 
 
 
 
 
 
